This cohort study uses data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II to assess racial/ethnic differences in the use of oral anticoagulants by patients with atrial fibrillation.
This cross-sectional study examines 30-day risk-standardized mortality rates for coronary artery bypass grafting, acute myocardial infarction, and heart failure at top-ranked US News & World Report cardiology vs nonranked hospitals.
This study calculates estimated 5-year number needed to treat values for the primary outcome of cardiovascular death or heart failure hospitalization with angiotensin receptor-neprilysin inhibitor therapy incremental to angiotensin-converting enzyme inhibitor in patients with heart failure with reduced ejection fraction (HFrEF) in the PARADIGM-HF trial.
This narrative review examines whether angiotensin II receptor blockade coupled with potentiation of key biological signaling pathways can favorably alter the course of heart failure with reduced ejection fraction.
This Editorial argues for the total cessation of clinical trials investigating cardiac stem cells because foundational data has been revealed as fraudulent and previous clinical trials as largely without positive result.
This cohort study uses data from the Transcatheter Valve Therapy Registry to examine health outcomes among patients undergoing transcatheter mitral valve repair for mitral regurgitation.
This secondary analysis of the ASTRONOMER randomized clinical trial assesses whether plasma levels of lipoprotein(a) have a linear or a threshold association with rate of progression among patients with calcific aorta valve stenosis.
This study uses Altmetric scores to identify and describe the articles in 4 major cardiovascular journals that garnered the most digital attention in 2017.
This cohort study determines whether proportion of genetically determined African ancestry is associated with increased electrocardiographic voltage and concentric LV hypertrophy in black compared with white individuals.
This secondary analysis of a randomized clinical trial assesses if different biomarkers provide information about the risk for all-cause and cause-specific mortality after acute coronary syndrome.
This study examines cohorts of Yanomami and Yekwana individuals in Venezuela to assess how age affects blood pressure rise over time in isolated communities without Western exposure.
This Viewpoint describes reasons why the Centers for Medicare and Medicaid Services should revisit a coverage decision affecting the ability of patients with pacemakers or implantable cardioverter-defibrillators to access magnetic resonance imaging.
This autopsy study tests whether epigenetic signatures characterize early fetal atherogenesis associated with maternal hypercholesterolemia and provides a quantitative estimate of the contribution of maternal cholesterol level to fetal lesion size.
This randomized survey study explores how communication tools and presentation formats influence the perception of the severity of atherosclerotic cardiovascular disease risk as well as the potential willingness to take medication therapy among patients in the Patient and Provider Assessment of Lipid Management Registry.
A woman in her late 40s presents with palpitations with near syncope, monomorphic ventricular tachycardia, and multiple normal test results. What would you do next?
Create a personal account or sign in to: